Shuqi Li

544 citations
26 papers · 353 indexed · h-index 11
Topics
Cancer, Lipids, and Metabolism (5 papers)Inflammatory Biomarkers in Disease Prognosis (5 papers)Epigenetics and DNA Methylation (3 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Shuqi Li

23 papers receiving 348 citations

Peers

Shuqi Li
Comparison fields: 5 of 76
  • Oncology 202
  • Pulmonary and Respiratory Medicine 101
  • Cancer Research 101
  • Surgery 49
  • Molecular Biology 46
Replace Qiu‐Fang Gao with:
Qiu‐Fang Gao China
Shubin Song China
Pietro Di Marino Italy
Eiki Ojima Japan
Yongling Ji China
Guodong Li China
A. Antón Torres Spain
Angélique Da Silva France
Yakup Bozkaya Türkiye
Zhangheng Huang China
Shuqi Li relative to Qiu‐Fang Gao China Qiu‐Fang Gao's profile →
Citations per field
00.5×1.5×
Qiu‐Fang Gao · 1×
Citations per year

Countries citing papers authored by Shuqi Li

Since Specialization
Citations

This map shows the geographic impact of Shuqi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuqi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuqi Li more than expected).

Fields of papers citing papers by Shuqi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuqi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuqi Li. The network helps show where Shuqi Li may publish in the future.

Co-authorship network of co-authors of Shuqi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shuqi Li. A scholar is included among the top collaborators of Shuqi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuqi Li. Shuqi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 4
5 3
6 1
7 12
8 8
9 7
10 2
11 14
12 8
13 11
14 23
15 21
16 31
17 31
18 6
19
[Prevalence of obstructive sleep apnea-hypopnea syndrome in adults aged over 20 years in Fuzhou city].
5
20
Phase II clinical trial report of treating lung cancer with Shen Yi Capsule
4

About Shuqi Li

Shuqi Li is a scholar working on Cancer Research, Oncology and Hematology, having authored 26 papers that have together received 353 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (5 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Oncology (202 citations), Cancer Research (101 citations) and Internal Medicine (18 citations). Shuqi Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Fan Sun, Yuhuan Jiang, Hou‐Qun Ying, Qiu‐Fang Gao, Xiaozhong Wang, Qing-Gen Chen, Lei Zhang, Lei Zhang, Lin Jin and Jing Zhang. Their work appears in journals such as Applied Physics Letters, Chemosphere and Frontiers in Psychology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026